Selected research
Industry Research
In Vitro Biology Service Industry Research Report 2026
Market perspective
The global In Vitro Biology Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the In Vitro Biology Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the In Vitro Biology Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the In Vitro Biology Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of In Vitro Biology Service include Oncodesign Services, NuChem Sciences Inc, Jubilant Biosys, Pharmaron, Melior Discovery, NUVISAN GmbH, Dalriada, Pharmacelsu and Paraza Pharma, Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global In Vitro Biology Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to In Vitro Biology Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In Vitro Biology Service Market by Company
Oncodesign Services
NuChem Sciences Inc
Jubilant Biosys
Pharmaron
Melior Discovery
NUVISAN GmbH
Dalriada
Pharmacelsu
Paraza Pharma, Inc
PORSOLT
Sygnature Discovery
Aurigene Pharmaceutical Services Ltd
Charles River Laboratories
HitGen Inc
Piramal Pharma Solutions
GenScript ProBio
Ichor Life Sciences, Inc
LAXAI Life Sciences Pvt. Ltd
ChemPartner
In Vitro Biology Service Segment by Type
Assay Development Services
High-throughput Screening Services
Mechanism of Action Research Services
Others
In Vitro Biology Service Segment by Application
Pharmaceutical Research and Development
Biotechnology
Disease Research
Others
In Vitro Biology Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Biology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Biology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Biology Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In Vitro Biology Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Assay Development Services
- High-throughput Screening Services
- Mechanism of Action Research Services
- Others
Applications
- Pharmaceutical Research and Development
- Biotechnology
- Disease Research
- Others
Companies covered
- Oncodesign Services
- NuChem Sciences Inc
- Jubilant Biosys
- Pharmaron
- Melior Discovery
- NUVISAN GmbH
- Dalriada
- Pharmacelsu
- Paraza Pharma, Inc
- PORSOLT
- Sygnature Discovery
- Aurigene Pharmaceutical Services Ltd
- Charles River Laboratories
- HitGen Inc
- Piramal Pharma Solutions
- GenScript ProBio
- Ichor Life Sciences, Inc
- LAXAI Life Sciences Pvt. Ltd
- ChemPartner
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 In Vitro Biology Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Assay Development Services
- 2.2.3 High-throughput Screening Services
- 2.2.4 Mechanism of Action Research Services
- 2.2.5 Others
- 2.3 In Vitro Biology Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Research and Development
- 2.3.3 Biotechnology
- 2.3.4 Disease Research
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 In Vitro Biology Service Breakdown Data by Type
- 3.1 Global In Vitro Biology Service Historic Market Size by Type (2021-2026)
- 3.2 Global In Vitro Biology Service Forecasted Market Size by Type (2027-2032)
4 In Vitro Biology Service Breakdown Data by Application
- 4.1 Global In Vitro Biology Service Historic Market Size by Application (2021-2026)
- 4.2 Global In Vitro Biology Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global In Vitro Biology Service Market Perspective (2021-2032)
- 5.2 Global In Vitro Biology Service Growth Trends by Region
- 5.2.1 Global In Vitro Biology Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 In Vitro Biology Service Historic Market Size by Region (2021-2026)
- 5.2.3 In Vitro Biology Service Forecasted Market Size by Region (2027-2032)
- 5.3 In Vitro Biology Service Market Dynamics
- 5.3.1 In Vitro Biology Service Industry Trends
- 5.3.2 In Vitro Biology Service Market Drivers
- 5.3.3 In Vitro Biology Service Market Challenges
- 5.3.4 In Vitro Biology Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top In Vitro Biology Service Players by Revenue
- 6.1.1 Global Top In Vitro Biology Service Players by Revenue (2021-2026)
- 6.1.2 Global In Vitro Biology Service Revenue Market Share by Players (2021-2026)
- 6.2 Global In Vitro Biology Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of In Vitro Biology Service Head Office and Area Served
- 6.4 Global In Vitro Biology Service Players, Product Type & Application
- 6.5 Global In Vitro Biology Service Manufacturers Established Date
- 6.6 Global In Vitro Biology Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America In Vitro Biology Service Market Size (2021-2032)
- 7.2 North America In Vitro Biology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America In Vitro Biology Service Market Size by Country (2021-2026)
- 7.4 North America In Vitro Biology Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe In Vitro Biology Service Market Size (2021-2032)
- 8.2 Europe In Vitro Biology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe In Vitro Biology Service Market Size by Country (2021-2026)
- 8.4 Europe In Vitro Biology Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific In Vitro Biology Service Market Size (2021-2032)
- 9.2 Asia-Pacific In Vitro Biology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific In Vitro Biology Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific In Vitro Biology Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America In Vitro Biology Service Market Size (2021-2032)
- 10.2 South America In Vitro Biology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America In Vitro Biology Service Market Size by Country (2021-2026)
- 10.4 South America In Vitro Biology Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa In Vitro Biology Service Market Size (2021-2032)
- 11.2 Middle East & Africa In Vitro Biology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa In Vitro Biology Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa In Vitro Biology Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Oncodesign Services
- 12.1.1 Oncodesign Services Company Information
- 12.1.2 Oncodesign Services Business Overview
- 12.1.3 Oncodesign Services Revenue in In Vitro Biology Service Business (2021-2026)
- 12.1.4 Oncodesign Services In Vitro Biology Service Product Portfolio
- 12.1.5 Oncodesign Services Recent Developments
- 12.2 NuChem Sciences Inc
- 12.2.1 NuChem Sciences Inc Company Information
- 12.2.2 NuChem Sciences Inc Business Overview
- 12.2.3 NuChem Sciences Inc Revenue in In Vitro Biology Service Business (2021-2026)
- 12.2.4 NuChem Sciences Inc In Vitro Biology Service Product Portfolio
- 12.2.5 NuChem Sciences Inc Recent Developments
- 12.3 Jubilant Biosys
- 12.3.1 Jubilant Biosys Company Information
- 12.3.2 Jubilant Biosys Business Overview
- 12.3.3 Jubilant Biosys Revenue in In Vitro Biology Service Business (2021-2026)
- 12.3.4 Jubilant Biosys In Vitro Biology Service Product Portfolio
- 12.3.5 Jubilant Biosys Recent Developments
- 12.4 Pharmaron
- 12.4.1 Pharmaron Company Information
- 12.4.2 Pharmaron Business Overview
- 12.4.3 Pharmaron Revenue in In Vitro Biology Service Business (2021-2026)
- 12.4.4 Pharmaron In Vitro Biology Service Product Portfolio
- 12.4.5 Pharmaron Recent Developments
- 12.5 Melior Discovery
- 12.5.1 Melior Discovery Company Information
- 12.5.2 Melior Discovery Business Overview
- 12.5.3 Melior Discovery Revenue in In Vitro Biology Service Business (2021-2026)
- 12.5.4 Melior Discovery In Vitro Biology Service Product Portfolio
- 12.5.5 Melior Discovery Recent Developments
- 12.6 NUVISAN GmbH
- 12.6.1 NUVISAN GmbH Company Information
- 12.6.2 NUVISAN GmbH Business Overview
- 12.6.3 NUVISAN GmbH Revenue in In Vitro Biology Service Business (2021-2026)
- 12.6.4 NUVISAN GmbH In Vitro Biology Service Product Portfolio
- 12.6.5 NUVISAN GmbH Recent Developments
- 12.7 Dalriada
- 12.7.1 Dalriada Company Information
- 12.7.2 Dalriada Business Overview
- 12.7.3 Dalriada Revenue in In Vitro Biology Service Business (2021-2026)
- 12.7.4 Dalriada In Vitro Biology Service Product Portfolio
- 12.7.5 Dalriada Recent Developments
- 12.8 Pharmacelsu
- 12.8.1 Pharmacelsu Company Information
- 12.8.2 Pharmacelsu Business Overview
- 12.8.3 Pharmacelsu Revenue in In Vitro Biology Service Business (2021-2026)
- 12.8.4 Pharmacelsu In Vitro Biology Service Product Portfolio
- 12.8.5 Pharmacelsu Recent Developments
- 12.9 Paraza Pharma, Inc
- 12.9.1 Paraza Pharma, Inc Company Information
- 12.9.2 Paraza Pharma, Inc Business Overview
- 12.9.3 Paraza Pharma, Inc Revenue in In Vitro Biology Service Business (2021-2026)
- 12.9.4 Paraza Pharma, Inc In Vitro Biology Service Product Portfolio
- 12.9.5 Paraza Pharma, Inc Recent Developments
- 12.10 PORSOLT
- 12.10.1 PORSOLT Company Information
- 12.10.2 PORSOLT Business Overview
- 12.10.3 PORSOLT Revenue in In Vitro Biology Service Business (2021-2026)
- 12.10.4 PORSOLT In Vitro Biology Service Product Portfolio
- 12.10.5 PORSOLT Recent Developments
- 12.11 Sygnature Discovery
- 12.11.1 Sygnature Discovery Company Information
- 12.11.2 Sygnature Discovery Business Overview
- 12.11.3 Sygnature Discovery Revenue in In Vitro Biology Service Business (2021-2026)
- 12.11.4 Sygnature Discovery In Vitro Biology Service Product Portfolio
- 12.11.5 Sygnature Discovery Recent Developments
- 12.12 Aurigene Pharmaceutical Services Ltd
- 12.12.1 Aurigene Pharmaceutical Services Ltd Company Information
- 12.12.2 Aurigene Pharmaceutical Services Ltd Business Overview
- 12.12.3 Aurigene Pharmaceutical Services Ltd Revenue in In Vitro Biology Service Business (2021-2026)
- 12.12.4 Aurigene Pharmaceutical Services Ltd In Vitro Biology Service Product Portfolio
- 12.12.5 Aurigene Pharmaceutical Services Ltd Recent Developments
- 12.13 Charles River Laboratories
- 12.13.1 Charles River Laboratories Company Information
- 12.13.2 Charles River Laboratories Business Overview
- 12.13.3 Charles River Laboratories Revenue in In Vitro Biology Service Business (2021-2026)
- 12.13.4 Charles River Laboratories In Vitro Biology Service Product Portfolio
- 12.13.5 Charles River Laboratories Recent Developments
- 12.14 HitGen Inc
- 12.14.1 HitGen Inc Company Information
- 12.14.2 HitGen Inc Business Overview
- 12.14.3 HitGen Inc Revenue in In Vitro Biology Service Business (2021-2026)
- 12.14.4 HitGen Inc In Vitro Biology Service Product Portfolio
- 12.14.5 HitGen Inc Recent Developments
- 12.15 Piramal Pharma Solutions
- 12.15.1 Piramal Pharma Solutions Company Information
- 12.15.2 Piramal Pharma Solutions Business Overview
- 12.15.3 Piramal Pharma Solutions Revenue in In Vitro Biology Service Business (2021-2026)
- 12.15.4 Piramal Pharma Solutions In Vitro Biology Service Product Portfolio
- 12.15.5 Piramal Pharma Solutions Recent Developments
- 12.16 GenScript ProBio
- 12.16.1 GenScript ProBio Company Information
- 12.16.2 GenScript ProBio Business Overview
- 12.16.3 GenScript ProBio Revenue in In Vitro Biology Service Business (2021-2026)
- 12.16.4 GenScript ProBio In Vitro Biology Service Product Portfolio
- 12.16.5 GenScript ProBio Recent Developments
- 12.17 Ichor Life Sciences, Inc
- 12.17.1 Ichor Life Sciences, Inc Company Information
- 12.17.2 Ichor Life Sciences, Inc Business Overview
- 12.17.3 Ichor Life Sciences, Inc Revenue in In Vitro Biology Service Business (2021-2026)
- 12.17.4 Ichor Life Sciences, Inc In Vitro Biology Service Product Portfolio
- 12.17.5 Ichor Life Sciences, Inc Recent Developments
- 12.18 LAXAI Life Sciences Pvt. Ltd
- 12.18.1 LAXAI Life Sciences Pvt. Ltd Company Information
- 12.18.2 LAXAI Life Sciences Pvt. Ltd Business Overview
- 12.18.3 LAXAI Life Sciences Pvt. Ltd Revenue in In Vitro Biology Service Business (2021-2026)
- 12.18.4 LAXAI Life Sciences Pvt. Ltd In Vitro Biology Service Product Portfolio
- 12.18.5 LAXAI Life Sciences Pvt. Ltd Recent Developments
- 12.19 ChemPartner
- 12.19.1 ChemPartner Company Information
- 12.19.2 ChemPartner Business Overview
- 12.19.3 ChemPartner Revenue in In Vitro Biology Service Business (2021-2026)
- 12.19.4 ChemPartner In Vitro Biology Service Product Portfolio
- 12.19.5 ChemPartner Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst